Nicotinamide Riboside

Basic information

  • Product Name:Nicotinamide Riboside
  • CasNo.:1341-23-7
  • MF:C11H15 N2 O5
  • MW:255.25

Physical and Chemical Properties

  • Purity:99%
  • Boiling Point:
  • Packing:
  • Throughput:
Inquiry

Product Details

CasNo: 1341-23-7

MF: C11H15 N2 O5

Quality manufacturer supply Nicotinamide Riboside 1341-23-7 in stock with high standard

  • Molecular Formula:C11H15 N2 O5
  • Molecular Weight:255.25
  • Vapor Pressure:3.05E-07mmHg at 25°C 
  • Refractive Index:1.549 
  • Boiling Point:646.2 °C at 760 mmHg 
  • Flash Point:344.6 °C 
  • PSA:116.25000 
  • Density:1.201g/cm3 
  • LogP:-1.69540 

NICOTINAMIDE RIBOSIDE(Cas 1341-23-7) Usage

benefits

Nicotinamide riboside (NR) is one of the viable natural precursors for the biosynthesis of NAD+ via two alternative pathways involving the purine nucleoside phosphorylase or the nicotinamide riboside kinase enzymes. Therapeutic benefits of nicotinamide riboside supplementation:Constant dietary supplementation of nicotinamide riboside has been shown to increase the NAD+ levels in middle aged to elderly people.It may support mitochondrial function.It may enhance memory and combat cognitive decline.It might lengthen your life.It might promote muscle quality and strength.It might counter the effects of a high-fat diet.In 2016 NR received the GRAS (Generally Recognized As Safe) status from the FDA. NR also demonstrated the potential to slow aging processes in mice models.

Biological Functions

Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme that, when reduced to NADH, serves as a reducing agent to donate electrons for oxidative phosphorylation and ATP synthesis in mitochondria. NAD+ is a critical cofactor for enzymes such as sirtuins, ADP-ribosyltransferases (ARTs), and Poly [ADP- ribose] polymerases (PARPs) and is continuously consumed by these enzymes. The NAD+/NADH ratio is a critical component of the redox state of the cell. (Verdin 2015). By some counts, NAD or the related NADP participates in a quarter of all cellular reactions (Opitz Heiland 2015). There are separate compartments of NAD+ in the nucleus, mitochondria, and cytoplasm (Verdin 2015). Nicotinamide riboside (NR) can be converted into NAD+ through an intermediate step in which it is converted into nicotinamide mononucleotide (NMN) by NR kinase (Nrk) and then to NAD+ by NMNATs. NR is naturally found in some foods but at very low quantities (e.g. low micromolar range). Historically, NR was difficult to obtain in large purified amounts, but thanks to advances in synthesis methods (Yang 2007), as of June 2013, it is sold as a dietary supplement.

Side effects

No serious adverse effects have been reported in human studies, though most of the studies so far have been short in duration and low in participant numbers. The need for larger scale and more robust human studies is critical if NR is to be properly evaluated.To date, some people have reported mild to moderate side effects, including nausea, fatigue, headaches, diarrhea, stomach upset and indigestion. While that seems to suggest NR is likely safe, the lack of large scale long-term studies means that this cannot be confirmed.As always, if you do decide to take a NR supplement and experience any adverse effects, you should cease taking it immediately and consult your doctor.

Safety

Nicotinamide riboside has a successful New Dietary Ingredient Notification with FDA (NDIN 882) for daily recommended intake of not more than 180 mg/d.Nicotinamide riboside is generally recognized as safe (FDA GRAS Notice No. 635) for use in vitamin waters, protein shakes, nutrition bars, gum, chews, and powdered beverages. Maximum use level 0.0057% by weight.

Mode of action

NAD+ is a critical and often rate-limiting factor in many aspects of mitochondrial and cellular function including DNA repair by PARPs, widespread acetylation and epigenetic effects by sirtuins, efficient production of ATP, and other pathways (Stein & Imai 2012). NAD+ levels decline with age as does the ratio of NAD+/NADH, with numerous studies suggesting that blunting this decline with NAD+ precursors or genetic manipulations can blunt fundamental features of aging (see below). The levels also decline with the high-fat diet but increase with calorie restriction and fasting (Stein & Imai 2012), leading some to argue that it can function as a calorie restriction mimetic.www.alzdiscovery.org

Definition

ChEBI: Nicotinamide riboside is a pyridine nucleoside consisting of nicotinamide with a beta-D-ribofuranosyl moiety at the 1-position. It is a metabolite found in or produced by Saccharomyces cerevisiae. It is an orally available form of vitamin B3 and precursor of nicotinamide adenine dinucleotide (NAD+) with potential use in the treatment of chemotherapy induced peripheral neuropathy (CIPN).

InChI:InChI=1/C11H13NO3/c13-10(6-7-12-8-11(14)15)9-4-2-1-3-5-9/h1-5,12H,6-8H2,(H,14,15)

1341-23-7 Relevant articles

Syntheses of nicotinamide riboside and derivatives: Effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells

Yang, Tianle,Chan, Noel Yan-Ki,Sauve, Anthony A.

, p. 6458 - 6461 (2007)

A new two-step methodology achieves ster...

The high-resolution crystal structure of periplasmic Haemophilus influenzae NAD nucleotidase reveals a novel enzymatic function of human CD73 related to NAD metabolism

Garavaglia, Silvia,Bruzzone, Santina,Cassani, Camilla,Canella, Laura,Allegrone, Gianna,Sturla, Laura,Mannino, Elena,Millo, Enrico,De Flora, Antonio,Rizzi, Menico

, p. 131 - 141 (2012)

Haemophilus influenzae is a major pathog...

Β - nicotinamide mononucleotide preparation method

-

, (2021/10/27)

The invention discloses a preparation me...

NICOTINAMIDE MONONUCLEOTIDE AND NICOTINAMIDE RIBOSIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF VIRAL INFECTIONS AND RESPIRATORY COMPLICATIONS, IN PARTICULAR CAUSED BY INFLUENZAVIRUS OR CORONAVIRUS

-

, (2021/10/30)

The present invention relates to Nicotin...

Chemical synthesis method of beta-nicotinamide mononucleotide

-

Paragraph 0040; 0044-0045, (2021/11/10)

The invention provides a chemical synthe...

Crystal form 1A and crystal form 1B of beta-nicotinamide ribose chloride and preparation method of crystal form 1A and crystal form 1B

-

Paragraph 0056-0060; 0074-0077, (2020/11/02)

The invention discloses a crystal form 1...

1341-23-7 Process route

1-(β-D-ribofuranosyl)-nicotinamide
1341-23-7

1-(β-D-ribofuranosyl)-nicotinamide

Conditions
Conditions Yield
NMN+ (oxyd. Nicotinamid-mononucleotid), enzymatische Bldg.;
nicotinamide
98-92-0,1255150-40-3

nicotinamide

1,2,3,5-tetraacetylribose
13035-61-5

1,2,3,5-tetraacetylribose

1-(β-D-ribofuranosyl)-nicotinamide
1341-23-7

1-(β-D-ribofuranosyl)-nicotinamide

Conditions
Conditions Yield
nicotinamide; 1,2,3,5-tetraacetylribose; With trimethylsilyl trifluoromethanesulfonate; In acetonitrile; at 20 ℃; for 1.5h;
With methanol; at 20 ℃; for 1h;
nicotinamide; 1,2,3,5-tetraacetylribose; With trimethylsilyl trifluoromethanesulfonate; In dichloromethane; at 30 - 40 ℃; Large scale;
With potassium carbonate; In dichloromethane; at 15 ℃; for 1h; Large scale;

1341-23-7 Upstream products

  • 98-92-0
    98-92-0

    nicotinamide

  • 13035-61-5
    13035-61-5

    1,2,3,5-tetraacetylribose

  • 936945-09-4
    936945-09-4

    2',3',5'-triacetyl ethyl nicotinate riboside

  • 53-84-9
    53-84-9

    NAD

1341-23-7 Downstream products

  • 98-92-0
    98-92-0

    nicotinamide

  • 19132-12-8
    19132-12-8

    1-[(2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofur-2-yl]-1,4-dihydropyridine-3-carboxamide

  • 23111-00-4
    23111-00-4

    3-carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium (β-D-nicotinamide riboside)

  • 1094-61-7
    1094-61-7

    nicotinamide mononucleotide